{"id":"W4399414899","doi":"10.1093/jjco/hyae048","title":"Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021–22","year":2024,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Medicine; Atezolizumab; Bevacizumab; Regimen; Lenvatinib; Sorafenib; Internal medicine; Hepatocellular carcinoma; Oncology; Systemic therapy; First line treatment; Cost effectiveness; Cancer; Chemotherapy; Nivolumab; Breast cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009065506,0.0002290566,0.00151206,0.0001973689,0.00003367631,0.000005889393,0.0001628103,0.0001771149,0.00005090599],"category_scores_gemma":[0.0006732264,0.0001183152,0.0006735871,0.0003629647,0.000182712,0.00009061176,0.00003968747,0.0003435396,0.000002993822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004421093,"about_ca_system_score_gemma":0.0009911391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001113465,"about_ca_topic_score_gemma":0.00005262096,"domain_scores_codex":[0.9964648,0.000301581,0.002211122,0.0002626764,0.0004038061,0.0003559586],"domain_scores_gemma":[0.9959211,0.001941587,0.0009569352,0.0003009584,0.0006024904,0.0002769691],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004899456,0.002184807,0.8976918,0.0003990587,0.0003149289,0.0001108275,0.00101763,0.00007257174,0.0001678721,0.00001749545,0.00002119237,0.09310233],"study_design_scores_gemma":[0.04653961,0.06085443,0.8448232,0.003178629,0.002284983,0.0002317604,0.001113482,0.01469898,0.001786949,0.00007705586,0.02411882,0.0002921155],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925873,0.004112065,0.00002930734,0.0005827452,0.0007034254,0.001872633,0.00003691735,0.000005543363,0.00007002163],"genre_scores_gemma":[0.9979128,0.001296152,0.0003162337,0.00001790511,0.0002765517,0.00009172354,0.00002067181,0.00002634854,0.00004159189],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09281021,"threshold_uncertainty_score":0.4824756,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09808055652630598,"score_gpt":0.378300364594102,"score_spread":0.280219808067796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}